Current Report Articles
FDA Alerts Customers of Voluntary Recall
FDALogo (May 20, 2022) – The Food and Drug Administration announced a voluntary recall by Drug Depot, LLC, doing business as APS Pharmacy (APS Pharmacy has no affiliation with the Kansas Hospital Association and Missouri Hospital Association's affiliate organization, APS), of certain unexpired compounded drugs due to a lack of sterility assurance. Administration of a non-sterile drug intended to be sterile may result in serious and potentially life-threatening infections. Patients should not use, and animal owners/caretakers should not administer, the recalled drugs from APS Pharmacy. APS Pharmacy, located in Palm Harbor, Florida, which compounds drugs intended for human use and drugs intended for animal use, initiated the voluntary nationwide recall via a recall letter dated March 15, 2022. The company has sent recall letters to all patients and animal owners who received the recalled drugs and are contacting all customers via telephone calls and emails. According to the FDA's announcement, the recalled drugs include "gonadorelin acetate," "testosterone cypionate in grapeseed oil," "testosterone cypionate/anastrozole in grapeseed oil," "testosterone cypionate/DHEA in grapeseed oil," and "testosterone cypionate/propionate in sesame seed oil" for human use, and "cyclosporin" and "tacrolimus" for animal ophthalmic use. These products were compounded between Dec. 21, 2021, and March 7, 2022. The recalled drugs, lot numbers, and do-not-use beyond date - the date when the compounded drug should no longer be used - are listed here.
--Karen Braman